ENGENE HOLDINGS INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.57 USD | -2.26% |
|
-4.92% | +36.19% |
| May. 15 | EnGene Holdings Inc. Approves Board Appointments | CI |
| Apr. 22 | Wells Fargo Starts enGene Holdings With Overweight Rating, $30 Price Target | MT |
Chart calendar enGene Holdings Inc.
640ed68a5f6.qmd3VrWx-ute4FMKLV_JsYnEKInwWnelaGKRduoXX9E._DgwMdP4tq0OqQN8QhGs3fryR-eRH0aUMRvAAadcOrTDUCAU4oeMkjmZBg~241ab7720fae8eaff90d004745c9a93b
Past events on enGene Holdings Inc.
| 2024-05-15 10:00 am | Annual General Meeting |
| 2024-05-03 11:30 am | American Urological Association Meeting |
| 2024-04-16 03:00 pm | Bloom Burton & Co. Healthcare Investor Conference |
| 2024-03-13 08:40 am | Leerink Partners Global Biopharma Conference |
| 2024-03-11 05:16 pm | Q1 2024 Earnings Release |
| 2024-01-29 07:12 am | Q4 2023 Earnings Release |
Annual results
| Fiscal Period | October | 2023 | 2024 |
|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -44,8 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -50,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -54,1 |
|
Net income Million USD | Released Forecast Spread | -99,9 | -54,1 |
|
EPS USD | Released Forecast Spread | -151 | -1,32 |
| Announcement Date | 29/01/24 | - |
Quarterly results
| Fiscal Period | October | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -6,51 | -9,09 | -12,8 | |||
|
EBIT Million USD | Released Forecast Spread | -10,9 | -14,0 | -17,5 | -20,8 | -21,8 | |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -13,5 | -16,1 | -19,7 | -20,7 | -21,7 | |
|
Net income Million USD | Released Forecast Spread | -13,5 | -16,1 | -19,6 | -20,6 | -21,7 | |
|
EPS USD | Released Forecast Spread | -0,46 -0,36 -27.78% | -0,27 | -0,29 | -0,35 | -0,67 | -0,69 |
| Announcement Date | 11/03/24 | - | - | - | - | - |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for enGene Holdings Inc.
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ENGN Stock
- Calendar enGene Holdings Inc.
